Filing excerpt
The decrease in ENBREL sales for the three months ended June 30, 2026 was primarily driven by lower net selling price of 22% resulting from the impact of U.S. Medicare Part D price setting under the IRA, effective January 1, 2026...
Government regulation is directly impacting revenue, with ENBREL sales decreasing due to a 22% drop in net selling price from the Inflation Reduction Act (IRA). Otezla is also expected to face similar declines starting in 2027, forcing the company to manage significant margin compression on key products.
Filing excerpt
The decrease in ENBREL sales for the three months ended June 30, 2026 was primarily driven by lower net selling price of 22% resulting from the impact of U.S. Medicare Part D price setting under the IRA, effective January 1, 2026...
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10qpricingPressureGet every 10-Q signal for Amgen and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Amgen this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/b87fb8c7-5ff2-4db4-9e3d-610ec8ef7ee8 returns this record as JSON. POST /v1/companies/enrich returns every signal for amgen.com.
{
"signal_id": "b87fb8c7-5ff2-4db4-9e3d-610ec8ef7ee8",
"signal_type": "sec-10q",
"signal_subtype": "pricingPressure",
"detected_at": "2026-08-11T08:11:01.218+00:00",
"company": {
"name": "Amgen",
"domain": "amgen.com"
},
"data": {
"detail": "Government regulation is directly impacting revenue, with ENBREL sales decreasing due to a 22% drop in net selling price from the Inflation Reduction Act (IRA). Otezla is also expected to face similar declines starting in 2027, forcing the company to manage significant margin compression on key products.",
"metrics": {
"pct": -22,
"timeframe": "current_quarter",
"pct_context": "ENBREL lower net selling price for the quarter"
},
"summary": "ENBREL net selling price drops 22% due to Medicare price setting under the IRA.",
"excerpts": "The decrease in ENBREL sales for the three months ended June 30, 2026 was primarily driven by lower net selling price of 22% resulting from the impact of U.S. Medicare Part D price setting under the IRA, effective January 1, 2026...",
"relevance": 0.9,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm",
"filing_date": "2026-08-04",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "06/30",
"sales_relevance": "Cost optimization needed",
"signal_category": "market",
"regions_mentioned": [
"United States"
]
}
}
curl https://signals.autobound.ai/v1/signals/b87fb8c7-5ff2-4db4-9e3d-610ec8ef7ee8 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"amgen.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.